MUKADAM SOPHIE enters BENITEC BIOPHARMA INC. with 6.02K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Indirect Derivatives

MUKADAM SOPHIE

Filed: 1/3/2025ACC: 0001062993-25-000257

InsiderMUKADAM SOPHIECIK 2050122

→

IssuerBENITEC BIOPHARMA INC.CIK 1808898

Officer· Chief Operating Officer

Since Jan 2025

6.02K

Baseline shares

0.00

Direct ownership

0 positions

406.47K

Derivative underlying

5 instruments

Security positions

6.02K indirect

Non-Derivative Holdings1

Common Stock, par value $0.0001 per share

Indirect

Shares owned6.02K

Total

6.02K indirect6.02K

Security Title	Shares Owned	Ownership Type
Common Stock, par value $0.0001 per share	6.02K	Indirect
Total	6.02K	6.02K indirect

Derivative Holdings5

Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

100K

Shares owned

N/A

Exercise price

5.21

Expiration

—

Exercise window

—

Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

5.29K

Shares owned

N/A

Exercise price

3.91

Expiration

—

Exercise window

—

Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

1.03K

Shares owned

N/A

Exercise price

79.90

Expiration

—

Exercise window

—

Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

141.00

Shares owned

N/A

Exercise price

50.66

Expiration

—

Exercise window

—

Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

300K

Shares owned

N/A

Exercise price

12.00

Expiration

—

Exercise window

—

Total

Underlying

406.47K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Options (right to buy) Direct	Common Stock	5.21	—	—	100K	N/A
Options (right to buy) Direct	Common Stock	3.91	—	—	5.29K	N/A
Options (right to buy) Direct	Common Stock	79.90	—	—	1.03K	N/A
Options (right to buy) Direct	Common Stock	50.66	—	—	141.00	N/A
Options (right to buy) Direct	Common Stock	12.00	—	—	300K	N/A
Total					406.47K	0.00